Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$2.72B |
| 2 |
Meta Platforms (Facebook)
META
|
+$660M |
| 3 |
Micron Technology
MU
|
+$605M |
| 4 |
Mastercard
MA
|
+$497M |
| 5 |
Tesla
TSLA
|
+$495M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.33B |
| 2 |
Visa
V
|
+$1.26B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 4 |
Lam Research
LRCX
|
+$699M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$681M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 79.37% |
| 2 | Technology | 4.49% |
| 3 | Healthcare | 2.99% |
| 4 | Financials | 2.85% |
| 5 | Industrials | 2.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4626
MYR Group
MYRG
$4.71B
| $4.11M | ﹤0.01% |
14,549
+9,232
| +174% | +$2.4M |
2017 Q3
34 quarters
|
|
4627
Innoviva
INVA
$1.49B
| $4.1M | ﹤0.01% |
176,077
-2,237
| -1% | -$48.2K |
2018 Q4
29 quarters
|
|
|
KE
4628
Kimball Electronics
KE
$677M
| $4.1M | ﹤0.01% |
173,039
+136,289
| +371% | +$3.6M |
2025 Q1
4 quarters
|
|
4629
Sonida Senior Living
SNDA
$1.76B
| $4.1M | ﹤0.01% |
127,066
+92,284
| +265% | +$3.09M |
2025 Q3
2 quarters
|
|
4630
PUT
Celcuity
CELC
$3.6B
| $4.1M | ﹤0.01% |
35,900
+12,000
| +50% | +$1.31M |
2025 Q3
2 quarters
|
|
|
PSIX
4631
CALL
Power Solutions International
PSIX
$1.03B
| $4.1M | ﹤0.01% |
67,300
+13,500
| +25% | +$963K |
2025 Q3
2 quarters
|
|
4632
PUT
Arrowhead Research
ARWR
$8.81B
| $4.09M | ﹤0.01% |
65,300
-1,400
| -2% | -$88.6K |
2017 Q3
34 quarters
|
|
|
VOYG
4633
CALL
Voyager Technologies
VOYG
$1.84B
| $4.09M | ﹤0.01% |
175,000
-103,500
| -37% | -$2.97M |
2025 Q2
3 quarters
|
|
4634
PUT
Novavax
NVAX
$2.07B
| $4.09M | ﹤0.01% |
502,800
-350,200
| -41% | -$3.17M |
2019 Q3
26 quarters
|
|
4635
PUT
PENN Entertainment
PENN
$2.02B
| $4.09M | ﹤0.01% |
272,100
-10,400
| -4% | -$145K |
2017 Q4
33 quarters
|
|
4636
CALL
Commercial Metals
CMC
$7.25B
| $4.09M | ﹤0.01% |
66,500
+30,400
| +84% | +$2.2M |
2013 Q2
51 quarters
|
|
|
AAT
4637
American Assets Trust
AAT
$1.31B
| $4.08M | ﹤0.01% |
221,856
-53,846
| -20% | -$1.01M |
2020 Q1
24 quarters
|
|
|
SEZL
4638
PUT
Sezzle
SEZL
$3.73B
| $4.08M | ﹤0.01% |
64,500
-48,400
| -43% | -$3.3M |
2025 Q2
3 quarters
|
|
4639
CALL
Axcelis
ACLS
$4.39B
| $4.08M | ﹤0.01% |
43,800
-2,500
| -5% | -$221K |
2020 Q1
24 quarters
|
|
4640
PUT
GlobalFoundries
GFS
$27.1B
| $4.07M | ﹤0.01% |
91,600
-72,300
| -44% | -$3.19M |
2021 Q4
17 quarters
|
|
4641
Aurinia Pharmaceuticals
AUPH
$2.09B
| $4.07M | ﹤0.01% |
274,574
-504,921
| -65% | -$7.38M |
2018 Q3
30 quarters
|
|
4642
Enovix
ENVX
$586M
| $4.07M | ﹤0.01% |
785,329
+588,873
| +300% | +$3.69M |
2025 Q3
2 quarters
|
|
4643
CALL
Copa Holdings
CPA
$5.53B
| $4.07M | ﹤0.01% |
35,800
-20,800
| -37% | -$2.73M |
2013 Q2
51 quarters
|
|
4644
CorVel
CRVL
$3.84B
| $4.07M | ﹤0.01% |
74,414
+16,545
| +29% | +$953K |
2025 Q1
4 quarters
|
|
4645
CALL
Schwab US Large-Cap Growth ETF
SCHG
$65.3B
| $4.07M | ﹤0.01% |
139,600
+23,900
| +21% | +$743K |
2020 Q4
21 quarters
|
|
4646
Pliant Therapeutics
PLRX
$63.8M
| $4.07M | ﹤0.01% |
3,226,599
+643,267
| +25% | +$812K |
2020 Q2
23 quarters
|
|
4647
Pacer US Small Cap Cash Cows 100 ETF
CALF
$3.6B
| $4.06M | ﹤0.01% |
90,556
+30,817
| +52% | +$1.4M |
2023 Q1
12 quarters
|
|
4648
PUT
BridgeBio Pharma
BBIO
$12.9B
| $4.06M | ﹤0.01% |
54,700
-56,700
| -51% | -$4.11M |
2021 Q1
20 quarters
|
|
4649
Granite Construction
GVA
$5.28B
| $4.06M | ﹤0.01% |
33,858
-129,519
| -79% | -$16.2M |
2015 Q1
44 quarters
|
|
4650
Zentalis Pharmaceuticals
ZNTL
$263M
| $4.05M | ﹤0.01% |
1,732,083
-232,172
| -12% | -$600K |
2020 Q2
23 quarters
|
|
Similar funds
Citadel Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Citadel Advisors held 14,860 positions worth $618B, down 7.1% from $666B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Citadel Advisors's Q1 2026 filing shows 2,347 new, 5,138 increased, 5,286 reduced and 2,003 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M. The largest sale was Amazon, an estimated $1.33B.
By sector, the portfolio is most concentrated in Miscellaneous at 79% of assets, down from 80% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q1 2026 buy was iShares 7-10 Year Treasury Bond ETF: 3,431,225 shares worth $327M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q1 2026, an estimated $2.72B increase.
- Citadel Advisors's biggest Q1 2026 reduction was Amazon, cutting an estimated $1.33B.
- Citadel Advisors fully exited CyberArk in Q1 2026, selling an estimated $305M.
- Citadel Advisors's ten largest holdings make up 22% of its $618B portfolio in Q1 2026.
- Citadel Advisors opened 2,347 new positions and closed 2,003 in Q1 2026.
- Citadel Advisors's portfolio value fell 7.1% quarter-over-quarter to $618B.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.